ADVANCED DRUG DELIVERY REVIEWS 期刊简介

ADVANCED DRUG DELIVERY REVIEWS
英文简介:

The aim of the Journal is to provide a forum for the critical analysis of advanced drug and gene delivery systems and their applications in human and veterinary medicine. The Journal has a broad scope, covering the key issues for effective drug and gene delivery, from administration to site-specific delivery.

In general, the Journal publishes review articles in a Theme Issue format. Each Theme Issue provides a comprehensive and critical examination of current and emerging research on the design and development of advanced drug and gene delivery systems and their application to experimental and clinical therapeutics. The goal is to illustrate the pivotal role of a multidisciplinary approach to modern drug delivery, encompassing the application of sound biological and physicochemical principles to the engineering of drug delivery systems to meet the therapeutic need at hand. Importantly the Editorial Team of ADDR asks that the authors effectively window the extensive volume of literature, pick the important contributions and explain their importance, produce a forward looking identification of the challenges facing the field and produce a Conclusions section with expert recommendations to address the issues.

Articles review the current status of a specific topic, giving equal emphasis to the identification of major conceptual and technological challenges to successful drug and gene delivery, to an evaluation of triumphs as well as shortcomings in current conceptual and technical approaches, and to a discussion of their possible solution.

中文简介:(来自Google、百度翻译)

该杂志的目的是为先进的药物和基因递送系统及其在人类和兽医学中的应用提供一个批判性分析的论坛。该杂志的范围很广,涵盖了有效药物和基因传递的关键问题,从给药到特定地点的传递。
通常,该杂志以主题发行形式发表评论文章。每个主题问题都对有关高级药物和基因递送系统的设计和开发及其在实验和临床治疗中的应用的当前和新兴研究进行了全面而严格的审查。目的是说明现代药物输送的多学科方法的关键作用,包括将合理的生物学和物理化学原理应用于药物输送系统的工程,以满足当前的治疗需求。重要的是,ADDR的编辑团队要求作者有效地浏览大量文献,挑选重要的贡献并解释其重要性,对该领域面临的挑战进行前瞻性识别,并提出结论部分,其中包含专家建议以解决这些问题。
文章回顾了特定主题的当前状态,同时强调了对成功药物和基因传递的主要概念和技术挑战的识别,评估当前概念和技术方法中的胜利和缺点,并讨论其可能的解决方案。

期刊ISSN
0169-409X
影响指数
15.315
最新CiteScore值
24.70 查看CiteScore评价数据
最新自引率
2.00%
官方指定润色网址
https://www.deeredit.com/?type=ss1
投稿语言要求

Improve the quality of the paper, eliminate grammar and spelling errors, increase readability, ensure accurate communication of viewpoints, enhance academic reputation, and increase the chances of the paper being accepted.

建议点击这个网址:https://www.deeredit.com/?type=ss2,资深审稿专家为您评估稿件质量,提供针对性改进建议,最终可助您极大提升目标期刊录用率

期刊官方网址

hot

https://www.peipusci.com/?type=9
杂志社征稿网址

hot

https://www.peipusci.com/?type=10
通讯地址
ELSEVIER SCIENCE BV, PO BOX 211, AMSTERDAM, NETHERLANDS, 1000 AE
偏重的研究方向(学科)
医学-药学
出版周期
Monthly
出版年份
1987
出版国家/地区
NETHERLANDS
是否OA
No
SCI期刊coverage
Science Citation Index Expanded(科学引文索引扩展)
NCBI查询
PubMed Central (PMC)链接 全文检索(pubmed central)
ADVANCED DRUG DELIVERY REVIEWS 期刊中科院JCR 评价数据
最新中科院JCR分区
大类(学科)
小类(学科)
综述期刊
医学
PHARMACOLOGY & PHARMACY(药学)1区
最新的影响因子
15.315
最新公布的期刊年发文量
年度总发文量 研究类文章占比
130 0.00%
总被引频次 278
影响因子趋势图
近年的影响因子趋势图(整体平稳趋势)

2022年预警名单预测最新

ADVANCED DRUG DELIVERY REVIEWS 期刊CiteScore评价数据
最新CiteScore值
24.70
年文章数 130
SJR
3.475
SNIP
2.994
CiteScore排名
序号 类别(学科) 排名 百分位
1 Pharmacology, Toxicology and Pharmaceutics Pharmaceutical Science #1/166
CiteScore趋势图
CiteScore趋势图
ADVANCED DRUG DELIVERY REVIEWS 投稿经验(由下方点评分析获得,3人参与,2738人阅读)
投稿录用比例: 多是约稿
审稿速度: 一般,3-8周
分享者 点评内容
没有更多了~
Copyright © 2014-2019 晟斯医学 All Rights Reserved. 备案号:苏ICP备11037034号-5 版权所有:南京孜文信息咨询有限公司